Published in AJR Am J Roentgenol on July 01, 2007
Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol (2013) 1.35
Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol (2008) 1.01
Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT. Eur Radiol (2013) 0.99
Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging (2009) 0.93
Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol (2014) 0.90
Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver (2014) 0.88
Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review. Ultrasonography (2015) 0.88
Fortuitously discovered liver lesions. World J Gastroenterol (2013) 0.82
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.81
Comparing enhancement and washout patterns of hepatic lesions between sonazoid-enhanced ultrasound and contrast-enhanced computed tomography. J Med Ultrason (2001) (2010) 0.78
Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol (2012) 0.77
Imaging findings of mimickers of hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Does the echogenicity of focal liver lesions on baseline gray-scale ultrasound interfere with the diagnostic performance of contrast-enhanced ultrasound? Eur Radiol (2009) 0.76
Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. Ultrasound (2013) 0.75
Focal liver lesions: one more example of discordance between contrast-enhanced sonography and CT pattern of enhancement. AJR Am J Roentgenol (2008) 0.75
Feasibility of Antegrade Contrast-enhanced US Nephrostograms to Evaluate Ureteral Patency. Radiology (2016) 0.75
A case of mucinous cystic neoplasm of the liver: description of Sonazoid-enhanced ultrasound imaging and histopathologic findings. J Med Ultrason (2001) (2012) 0.75
Microbubble-enhanced US in body imaging: what role? Radiology (2010) 2.57
Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none? Hepatology (2011) 2.26
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr (2008) 2.25
Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc Natl Acad Sci U S A (2012) 1.90
Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol (2002) 1.88
Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology (2004) 1.74
Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol (2008) 1.63
Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology (2007) 1.61
Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med (2007) 1.54
Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology (2003) 1.54
High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res (2002) 1.40
Iterative reconstruction algorithm for CT: can radiation dose be decreased while low-contrast detectability is preserved? Radiology (2013) 1.39
IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics (2011) 1.38
High frequency nonlinear B-scan imaging of microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.36
Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol (2008) 1.35
An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol (2006) 1.31
Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics (2004) 1.30
Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol (2003) 1.29
Anatomic variation in intrahepatic bile ducts: an analysis of intraoperative cholangiograms in 300 consecutive donors for living donor liver transplantation. Korean J Radiol (2003) 1.26
Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization. J Hepatol (2010) 1.24
Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology (2003) 1.19
Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am J Roentgenol (2010) 1.17
Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol (2008) 1.15
Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent. Ultrasound Med Biol (2011) 1.12
Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol (2002) 1.08
Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol (2006) 1.08
High-frequency 3-D color-flow imaging of the microcirculation. Ultrasound Med Biol (2003) 1.07
MR assessment of abdominal circulation in Fontan physiology. Int J Cardiovasc Imaging (2014) 1.07
Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. Radiology (2011) 1.07
Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med (2007) 1.06
MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. Gastrointest Endosc (2002) 1.02
Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology (2002) 1.02
Primary colorectal lymphoma: spectrum of imaging findings with pathologic correlation. Eur Radiol (2002) 1.02
Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics (2002) 1.02
Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging (2011) 1.01
Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol (2008) 1.01
Extrahepatic spread of hepatocellular carcinoma: a pictorial review. Eur Radiol (2002) 1.00
Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultrasound Med Biol (2005) 1.00
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology (2011) 0.99
Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer. Ultrasound Med Biol (2013) 0.98
Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol (2003) 0.98
Investigating perfluorohexane particles with high-frequency ultrasound. Ultrasound Med Biol (2006) 0.97
Quantification of flow using ultrasound and microbubbles: a disruption replenishment model based on physical principles. Ultrasound Med Biol (2009) 0.97
Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med (2007) 0.96
Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual-phase three-dimensional MR angiography. J Magn Reson Imaging (2002) 0.96
High-frequency, nonlinear flow imaging of microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 0.96
Usefulness of known computed tomography and clinical criteria for diagnosing strangulation in small-bowel obstruction: analysis of true and false interpretation groups in computed tomography. World J Surg (2003) 0.95
Scirrhous gastric carcinoma: endoscopy versus upper gastrointestinal radiography. Radiology (2004) 0.94
Primary extrapulmonary small cell carcinoma involving the stomach or duodenum or both: findings on CT and barium studies. AJR Am J Roentgenol (2003) 0.94
Imaging of malignant liver masses: characterization and detection. Ultrasound Q (2006) 0.93
Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging (2009) 0.93
Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol (2008) 0.93
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma. Cancer (2015) 0.92
Acoustic and kinetic behaviour of definity in mice exposed to high frequency ultrasound. Ultrasound Med Biol (2008) 0.92
A model for reflectivity enhancement due to surface bound submicrometer particles. Ultrasound Med Biol (2006) 0.92
Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging (2014) 0.92
Imaging of focal liver lesions. Semin Roentgenol (2009) 0.92
The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets. Ultrasonics (2013) 0.91
CT of prominent pericolic or perienteric vasculature in patients with Crohn's disease: correlation with clinical disease activity and findings on barium studies. AJR Am J Roentgenol (2002) 0.91
Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res (2003) 0.91
Small (<or= 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol (2004) 0.91
Optical studies of vaporization and stability of fluorescently labelled perfluorocarbon droplets. Phys Med Biol (2012) 0.90
Vascular complications after living related liver transplantation: evaluation with gadolinium-enhanced three-dimensional MR angiography. AJR Am J Roentgenol (2003) 0.90
Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol (2009) 0.90
Diagnosis of intrahepatic and common duct stones: combined unenhanced and contrast-enhanced helical CT in 1090 patients. Abdom Imaging (2006) 0.89
Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med (2002) 0.88
Portal and hepatic vein thrombosis in liver abscess: CT findings. Eur J Radiol (2006) 0.88
Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol (2008) 0.88
Hepatic artery pseudoaneurysms in adult living-donor liver transplantation: efficacy of CT and Doppler sonography. AJR Am J Roentgenol (2005) 0.88
Inter- and intra-operator reliability and repeatability of shear wave elastography in the liver: a study in healthy volunteers. Ultrasound Med Biol (2013) 0.87
Enhancement of hepatic hemangiomas with levovist on coded harmonic angiographic ultrasonography. J Ultrasound Med (2002) 0.87
Primary malignant melanoma of the rectum: CT findings in eight patients. Radiology (2004) 0.87
Transit time kinetics in ordered and disordered vascular trees. Phys Med Biol (2003) 0.87
Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q (2006) 0.87
Microbubble mediated sonoporation of cells in suspension: clonogenic viability and influence of molecular size on uptake. Ultrasonics (2010) 0.86
Investigation of the effects of microbubble shell disruption on population scattering and implications for modeling contrast agent behavior. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 0.86
Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis? Ultrasound Med Biol (2011) 0.86
Palliative percutaneous tube enterostomy in afferent-loop syndrome presenting as jaundice: clinical effectiveness. J Vasc Interv Radiol (2002) 0.86
Early biliary complications of laparoscopic cholecystectomy: evaluation on T2-weighted MR cholangiography in conjunction with mangafodipir trisodium-enhanced 3D T1-weighted MR cholangiography. AJR Am J Roentgenol (2004) 0.86
CT during hepatic arteriography and portography: an illustrative review. Radiographics (2002) 0.85